Multicenter Phase 1b/2a Clinical Trial of Radioprotectant BIO 300 Oral Suspension for Patients with Non-Small Cell Lung Cancer Receiving Concurrent Chemoradiotherapy (vol 118, pg 404, 2023)

被引:0
|
作者
Simone II, C. B.
Serebrenik, A. A.
Gore, E. M.
机构
关键词
D O I
10.1016/j.ijrobp.2024.02.009
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1029 / 1029
页数:1
相关论文
共 50 条
  • [1] Multicenter Phase 1b/2a Clinical Trial of Radioprotectant BIO 300 Oral Suspension for Patients With Non-Small Cell Lung Cancer Receiving Concurrent Chemoradiotherapy
    Simone, Charles B.
    Serebrenik, Artur A.
    Gore, Elizabeth M.
    Mohindra, Pranshu
    Brown, Stephen L.
    Wang, Ding
    Vujaskovic, Zeljko
    Menon, Smitha
    Thompson, Jonathan
    Fine, Gil
    Kaytor, Michael D.
    Movsas, Benjamin
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 118 (02): : 404 - 414
  • [2] A Phase 1b/2a Study Evaluating the Pharmacokinetics, Safety, and Efficacy of Nanogenistein in Combination with Chemoradiotherapy for Non-small Cell Lung Cancer
    Simone, C. B., II
    Movsas, B.
    Gore, E. M.
    Mohindra, P.
    Vujaskovic, Z.
    Wang, D.
    Ajlouni, M.
    Menon, S.
    Thompson, J.
    Brown, S. L.
    Kurman, M.
    Dykstra, J. C.
    Rillo, L.
    Ingram, M.
    Serebrenik, A.
    Kaytor, M. D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : S103 - S103
  • [3] A Phase 1b/2a Study Evaluating the Pharmacokinetics, Safety, and Efficacy of Nano-Genistein and Chemoradiotherapy for Non-Small Cell Lung Cancer
    Kaytor, M. D.
    Brown, S. L.
    Arapi, I.
    Kurman, M.
    Dykstra, J. C.
    Rillo, L.
    Ingram, M.
    Poppitz, S.
    Menon, S.
    Thompson, J.
    Wang, D.
    Ajlouni, M.
    Gore, E. M.
    Movsas, B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E688 - E688
  • [4] Safety and Efficacy of HL301 In Radiation Pneumonitis in Patients With Unresectable Non-Small Cell Lung Cancer Receiving Curative Concurrent Chemoradiotherapy: A Multicenter, Randomized, Double-Blinded, Placebo- Controlled, Phase 2a Clinical Trial
    Kim, Kyung Hwan
    Kang, Nahyun
    Song, Si Yeol
    Kim, Hak Jae
    Kim, Yeon-Sil
    Oh, Mi Jin
    Cho, Jaeho
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : 432 - 438
  • [5] A phase 1b trial of the combination of an all-oral regimen of capecitabine and erlotinib in advanced non-small cell lung cancer in Caucasian patients
    Rajiv Kumar
    Shir Kiong Lu
    Anna Minchom
    Adam Sharp
    Michael Davidson
    Ranga Gunapala
    Timothy A. Yap
    Jaishree Bhosle
    Sanjay Popat
    Mary E. R. O’Brien
    Cancer Chemotherapy and Pharmacology, 2016, 77 : 375 - 383
  • [6] A phase 1b trial of the combination of an all-oral regimen of capecitabine and erlotinib in advanced non-small cell lung cancer in Caucasian patients
    Kumar, Rajiv
    Lu, Shir Kiong
    Minchom, Anna
    Sharp, Adam
    Davidson, Michael
    Gunapala, Ranga
    Yap, Timothy A.
    Bhosle, Jaishree
    Popat, Sanjay
    O'Brien, Mary E. R.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 77 (02) : 375 - 383
  • [7] Phase 1b Trial of Cabozantinib or Cabozantinib Plus Atezolizumab in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
    Lim, F.
    Ponce, S.
    Patel, S.
    Van Herpen, C.
    Kurkjian, C.
    Lou, Y.
    Liu, Y.
    Ramsingh, G.
    Pal, S.
    Neal, J.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S405 - S406
  • [8] Clinical Outcomes of the HIV Protease Inhibitor Nelfinavir With Concurrent Chemoradiotherapy for Unresectable Stage IIIA/IIIB Non-Small Cell Lung Cancer: A Phase 1/2 Trial
    Rengan, Ramesh
    Mick, Rosemarie
    Pryma, Daniel A.
    Lin, Lilie Leming
    Christodouleas, John
    Plastaras, John P.
    Simone, Charles B., II
    Gupta, Anjali K.
    Evans, Tracey L.
    Stevenson, James P.
    Langer, Corey J.
    Kucharczuk, John
    Friedberg, Joseph
    Lam, Sarah
    Patsch, Dana
    Hahn, Stephen M.
    Maity, Amit
    JAMA ONCOLOGY, 2019, 5 (10) : 1464 - 1472
  • [9] Radiotherapy combined with gefitinib for patients with locally advanced non-small cell lung cancer who are unfit for surgery or concurrent chemoradiotherapy: a phase II clinical trial
    Fu, Zhixue
    Yang, Xu
    Wang, Wenqing
    Deng, Lei
    Zhang, Tao
    Bi, Nan
    Wang, Xiaozhen
    Chen, Dongfu
    Zhou, Zongmei
    Wang, Luhua
    Liang, Jun
    RADIATION ONCOLOGY, 2020, 15 (01)
  • [10] Radiotherapy combined with gefitinib for patients with locally advanced non-small cell lung cancer who are unfit for surgery or concurrent chemoradiotherapy: a phase II clinical trial
    Zhixue Fu
    Xu Yang
    Wenqing Wang
    Lei Deng
    Tao Zhang
    Nan Bi
    Xiaozhen Wang
    Dongfu Chen
    Zongmei Zhou
    Luhua Wang
    Jun Liang
    Radiation Oncology, 15